Oligo Metastatic renal cell carcinoma: SBRT, if, when and how?

被引：0
|
作者：
Marvaso, G. [1 ]
Corrao, G. [1 ]
Oneta, O. [1 ]
Gugliandolo, S. G. [1 ]
Pepa, M. [1 ]
Cecconi, A. [1 ]
Gandini, S. [2 ]
Piperno, G. [1 ]
Rocca, M. Cossu [3 ]
Verri, E. [3 ]
Aurilio, G. [3 ]
Corso, F. [2 ]
Cullura, D. [3 ]
Rondi, E. [4 ]
Vigorito, S. [4 ]
Nole, F. [3 ]
Orecchia, R. [5 ]
Jereczek-Fossa, B. A. [1 ]
机构：
[1] IEO European Inst Oncol IRCCS, Div Radiotherapy, Milan, Italy
[2] IEO European Inst Oncol IRCCS, Dept Expt Oncol, Milan, Italy
[3] IEO European Inst Oncol IRCCS, Div Med Oncol, Milan, Italy
[4] IEO European Inst Oncol IRCCS, Unit Med Phys, Milan, Italy
[5] IEO European Inst Oncol IRCCS, Sci Direct, Milan, Italy
来源：
RADIOTHERAPY AND ONCOLOGY | 2020年 / 152卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
PO-1218
引用
收藏
页码：S641 / S642
页数：2
相关论文
共 50 条
  • [11] Surveillance for renal cell carcinoma: Why and how? When and how often?
    Klatte, Tobias
    Lam, John S.
    Shuch, Brian
    Belldegrun, Arie S.
    Pantuck, Allan J.
    UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2008, 26 (05) : 550 - 554
  • [12] STUDY OF 2'5' OLIGO (A) SYNTHETASE IN PATIENTS WITH METASTATIC RENAL-CELL CARCINOMA
    VAKALIKOS, J
    DIMASIS, N
    PEFTULIDIS, S
    GALAKTIDOU, G
    KORTSARIS, AH
    INTERNATIONAL JOURNAL OF BIOLOGICAL MARKERS, 1995, 10 (02): : 113 - 114
  • [13] TRENDS IN SBRT FOR INOPERABLE RENAL CELL CARCINOMA
    Stone, Benjamin V.
    Nguyen, David-Dan
    Filipas, Dejan K.
    Labban, Muhieddine
    Beatrici, Edoardo
    Cole, Alexander P.
    Malone, Shawn
    Wallis, Christopher J. D.
    Trinh, Quoc-Dien
    Morgan, Scott C.
    Roy, Soumyajit
    JOURNAL OF UROLOGY, 2023, 209 : E643 - E643
  • [14] Surgery in renal cell carcinoma-when, whom and how?
    Lenart, Sebastian
    Berger, Ingrid
    Hartig, Nikolaus
    Madersbacher, Stephan
    Ponholzer, Anton
    MEMO-MAGAZINE OF EUROPEAN MEDICAL ONCOLOGY, 2019, 12 (04) : 347 - 351
  • [15] Invited commentary: When and how to initiate systemic therapy in treating favorable risk metastatic renal cell carcinoma
    Inoue, Takahiro
    CURRENT UROLOGY, 2021, 15 (04) : 185 - 186
  • [16] Metastatic renal cell carcinoma
    Gschwend, JE
    Huland, E
    UROLOGE A, 2002, 41 (03): : 219 - 220
  • [17] Metastatic renal cell carcinoma
    Robert C. Flanigan
    Steven C. Campbell
    Joseph I. Clark
    Maria M. Picken
    Current Treatment Options in Oncology, 2003, 4 (5) : 385 - 390
  • [18] How We Treat Brain Metastases in Metastatic Renal Cell Carcinoma
    Ramalingam, Sundhar
    George, Daniel J.
    Harrison, Michael R.
    CLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY, 2018, 16 (02) : 110 - 114
  • [19] How molecularly similar are primary and metastatic tissues in renal cell carcinoma?
    Kahya, Burcu Ulas
    Sutcuoglu, Osman
    Ozdemir, Nuriye
    Yazici, Ozan
    LANCET ONCOLOGY, 2022, 23 (07): : E316 - E316
  • [20] Role of SBRT in patients with metastatic renal carcinoma: experience in our center
    Garre Cristau, Josep
    Gomez-Puerto, Diego
    Geng-Cahyaume, Abraham A. A.
    Altabas, Manuel
    Marmolejo-Castaneda, David
    Rezqallag-Aron, Alejandra
    Morales-Barrera, Rafael
    Gonzalez, Macarena
    Carles Galceran, Joan
    Suarez, Cristina
    Maldonado-Pijoan, Xavier
    RADIOTHERAPY AND ONCOLOGY, 2024, 194 : S2580 - S2581
12345